Nina Beil
Papers
1
Total Citations
3
H-Index
1
About
Nina Beil is a trailblazer in the development of high-throughput cell-based screening technologies, with a primary focus on creating cost-effective and time-efficient platforms for preclinical research. Her most-cited work, "High-Density Cell Arrays for Genome-Scale Phenotypic Screening" (2019), introduces a transformative approach to cell-based assays, enabling researchers to conduct genome-scale phenotypic screens without the prohibitive costs and labor traditionally associated with such studies. By engineering high-density cell arrays, Beil has significantly lowered the barriers to large-scale biological testing, allowing for faster and more accessible drug discovery and functional genomics. Though her citation count is still growing—reflecting the nascent stage of this technology—her contributions are already recognized as foundational in the field of high-content screening. Beil’s work stands out for its practical impact, promising to accelerate preclinical development of biologics and therapeutic targets. Her innovative methodology is poised to become a standard tool in laboratories worldwide, marking her as a rising leader in the intersection of bioengineering and phenotypic screening.
Research Focus
Key Achievements
Top Papers
- 1High-Density Cell Arrays for Genome-Scale Phenotypic Screening3 citations · 2019